Skip to main content

Preclinical Neurology Deal Benchmarks

Median Upfront
$47M
Range: $13M - $88M
Total Deal Value
$1.1B
Range: $390M - $1.8B
Royalty Rate
4.9% - 9.9%
Tiered up to 13.9%
Dev Milestones
$619M
Range: $219M - $1.0B

Market Analysis

Preclinical neurology licensing deals carry a median total deal value of $1.1B, with upfront payments ranging from $13M to $88M. At this stage, deal structures are heavily milestone-weighted, reflecting the significant clinical risk ahead. The recommended split allocates 4% to upfront and 96% to milestones.

The neurology landscape at the preclinical stage is characterized by moderate competitive intensity with significant unmet need in neurodegenerative indications. Development milestones average $619M, regulatory milestones contribute $277M, and commercial milestones reach $171M. Disease-modifying therapies and novel CNS delivery platforms are attracting increasing licensee interest following breakthroughs in amyloid-targeted approaches.

Royalty rates for preclinical neurology deals range from 4.9% to 9.9% at the base tier, with high-tier escalation to 13.9%. Earlier-stage royalties are at the lower end of industry ranges, reflecting higher clinical risk.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

What is the average upfront payment for preclinical neurology deals?
Preclinical neurology deals average $47M in upfront payments, ranging from $13M to $88M. The upfront allocation of 4% of total deal value reflects the clinical stage risk profile.
How are preclinical neurology deal milestones structured?
Milestones account for approximately 96% of total deal value. Development milestones ($619M) represent the largest component, followed by commercial milestones ($171M) and regulatory milestones ($277M).
What royalty rates are typical for preclinical neurology licensing?
Base royalty rates range from 4.9% to 9.9%, with tiered escalation to 8.9%-13.9% on peak sales. Rates are influenced by modality, competitive positioning, and territorial scope.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.

Start Calculating
For Funds & Advisors

Need the full deal landscape?

The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.

Configure Brief — $2,500All-inclusive · White-label · Walkthrough included